Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.88−0.03 (-3.52%)
Close on Nov 13, 2026Market cap $7.06MP/E –Yield –
Immuron operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2026 it was -49.9%, against -73.3% the year before. The highest annual figure on record is -49.9% in fiscal 2026.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -49.9% | +23.4 |
| FY2025 | Jun 30, 2025 | -73.3% | +45.0 |
| FY2024 | Jun 30, 2024 | -118.3% | +79.4 |
| FY2023 | Jun 30, 2023 | -197.8% | +177.3 |
| FY2022 | Jun 30, 2022 | -375.0% | +5373.4 |
| FY2021 | Jun 30, 2021 | -5748.5% | −5633.1 |
| FY2020 | Jun 30, 2020 | -115.4% | +79.7 |
| FY2019 | Jun 30, 2019 | -195.0% | +14.0 |
| FY2018 | Jun 30, 2018 | -209.0% | +272.5 |
| FY2017 | Jun 30, 2017 | -481.5% | – |
See a number that looks wrong?